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Abstract
Smokers have a higher prevalence of major depressive episodes and depressive symptoms than the general population, but
whether this association is causal, or is due to confounding or reverse causation is uncertain because of the problems
inherent in some epidemiological studies. Mendelian randomization, in which a genetic variant is used as a surrogate for
measuring exposure, is an approach which may be used to better understand this association. We investigated the
rs1051730 single nucleotide polymorphism in the nicotine acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4),
associated with smoking phenotypes, to determine whether women who continued to smoke were also more likely to
report a low mood during pregnancy. We found among women who smoked pre-pregnancy, those with the 1051730 T
allele smoked more and were less likely to quit smoking during pregnancy, but were also less likely to report high levels of
depressed mood at 18 weeks of pregnancy (per allele OR=0.84, 95%CI 0.72 to 0.99, p=0.034). The association between
genotype and depressed mood was limited to women who were smokers prior to pregnancy, with weak evidence of an
interaction between smoking status and genotype (p=0.07). Our results do not support a causal role of smoking on
depressed mood, but are consistent with a self-medication hypothesis, whereby smoking is used to alleviate symptoms of
depression. A replication study using multiple genetic variants which influence smoking via different pathways is required
to confirm these findings and provide evidence that the genetic variant is reflecting the effect of quitting smoking on
depressed mood, and is not directly affecting mood.
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Introduction
Cigarette smoking and a depressive mood are highly co-morbid;
however, the mechanism underlying this association is poorly
understood [1]. Cigarette smokers often report that smoking can
alleviate feelings of depression; thus feeling depressed may cause
people to smoke as a way of self medicating. Alternatively, smoking
may increase the risk of low mood via alterations in neurotrans-
mitter pathways following chronic exposure. A further explanation
is that other factors (confounders), such as social position, explain
the observed association. Unfortunately observational studies
cannot provide evidence of causation and so are unable to resolve
this question [1].
Cigarette smoking during pregnancy is associated with increased
risk of infant morbidity and mortality [2,3], a fact which is made
clear to women through concerted health education campaigns
aimed at stopping women from smoking during pregnancy [4,5].
Thus pregnancy is a situation characterized by considerable health
and social pressure to stop smoking. Pregnancy therefore provides
us with a window in which, rather than women stopping smoking
for personal health reasons, there are women who stop smoking in
high numbers because of concern for the health of their offspring. If
smoking causes depressive mood, women who continue to smoke
through pregnancy should report higher levels of depressed mood
than those who stop smoking. However, if low mood rendered it
difficult for women to give up smoking the same association would
be seen. Similarly, if sociodemographic and behavioural factors
were related both to the inability to stop smoking and to depressive
mood ((i.e, the association is generated by confounding), the same
association would again be seen. Therefore, in order to be able to
make a casual interpretation in this situation we need an instrument
(a surrogate for measuring smoking) which influences the tendency
to smoke during pregnancy independently of mood.
Mendelian randomization uses genetic variation with known
functional consequences to examine the causal effects of a
modifiable exposure, such as tobacco use, on an associated
outcome, such as depression [6]. In this study, we used a genetic
variant known to be associated with continuing smoking during
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As genotype is determined at conception it cannot be susceptible
to reverse causation (although it is theoretically possible that the
same genotype could itself be associated with depressed mood).
The rs1051730 genetic variant in the nicotine acetylcholine
receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) has been
found to be robustly associated with number of cigarettes smoked
per day among those who smoke in genome wide association
studies [7,8]. We have previously showed an association between
this SNP and the risk of continuing smoking during pregnancy in a
large population based study of pregnant women [9]. To the best
of our knowledge, there have been no previous reports showing an
association of this genotype with depression or depressed mood.
We used this same cohort of women to determine whether
continued smoking during pregnancy is associated with an
increased risk of depressed mood, using rs1051730 as an
instrumental variable in a Mendelian randomization analysis.
Methods
Sample
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a population-based prospective study investigating
factors that affect the health and development of children and their
parents. The study methods are described in detail elsewhere
(http://www.alspac.bris.ac.uk and [10]). In brief, pregnant women
living in Bristol, England who had an expected date of delivery
between April 1991 and December 1992 were eligible to
participate in the study. 14 541 pregnant women enrolled in the
study. Detailed information on exclusion criteria for this analysis
and numbers with missing data is given in Figure 1.
Ethical approval for the study was obtained from the ALSPAC
Law and Ethics Committee and from three health authorities
covering the Bristol area in November 1989 (Bristol and Weston),
April 1990 (Southmead) and June 1990 (Frenchay). Written consent
was obtained from all participants who took part in this study.
Measurement of depressed mood
Women completed the Edinburgh Postnatal Depression Scale
(EPDS) by questionnaire at 18 and 32 weeks of pregnancy. This
questionnaire has 10 questions each with a maximum score of
3 points, with a higher score indicating a greater level of depressed
mood. We used a cut-off point of greater than or equal to 13 on
the EPDS to determine women with depressed mood for our
primary analyses. This is a well-established cut-off point for
determining low mood in pregnancy and in the postpartum period
[11,12]. Sensitivity analyses were also carried out using cut-offs of
greater than or equal to 10, 11 and 12.
Measurement of smoking status
Smoking behaviour of women before and during pregnancy was
determined from self-reported questionnaires completed at 18
weeks gestation, asking about lifetime, pre-pregnancy and first
trimester smoking status (current smoker, former smoker, never
smoker) and, among current smokers, quantity of cigarettes
smoked. Data on smoking quantity among current smokers was
categorized into ,10 and $10 cigarettes per day.
Figure 1. Flow-diagram of participants in the study, and reasons for exclusions.
doi:10.1371/journal.pone.0021689.g001
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Genotyping was undertaken by KBioscience Ltd. Ltd (www.
kbioscience.co.uk), who use their own form of competitive allele
specific PCR system (KASPar) and Taqman
TM for SNP analysis.
Statistical analysis
Logistic regression analyses were used to test for associations
between variables with caseness based on the EPDS (score $13) as
the outcome. The interaction between genotype and smoking on
EPDS score at 18 weeks pregnancy was tested by comparing a
model with and without an interaction term between the two
variables, using a likelihood ratio test. If genotype is associated
with depressed mood independently of smoking status we should
see a similar association between genotype and depressed mood
for both smokers and non-smokers pre-pregnancy, and no
interaction between genotype and smoking status on risk of
depressed mood. Assumptions of Hardy-Weinberg Equilibrium
were formally tested using a chi-squared test. Instrumental
variable estimation of the effect of continuing smoking on the
risk of depressed mood (defined by an EPDS score of greater than
12) was performed using two-stage least squares using the
rs1051730 genotypes under an additive model as the instrumental
variable. Two stage least squares estimation proceeds by first
fitting the regression of continuing smoking (exposure) on
rs1051730 genotypes (instrument). In the second stage the
depressed mood indicator (outcome) is regressed on the predicted
values of continuing smoking, the coefficient of which is the
estimate of the causal effect. Importantly the standard errors of the
second stage parameter estimates are appropriately corrected
(increased) to account for the uncertainty in the predicted values of
the exposure from the first stage. All analysis was done using Stata
11.0 (Stata Corporation, College Station, Texas).
Results
Pre-pregnancy smoking status and depressed mood at
18 weeks of pregnancy
Of the 6294 women included in this study, 33.2% smoked prior
to becoming pregnant, 26.8% of whom (560/2 090) reported
quitting smoking in the first trimester of pregnancy.13.6% of
women in this study reporting a depressed mood at 18 weeks of
pregnancy (i.e., a score of 13 or more on the EPDS), with the
women who reported smoking prior to pregnancy being 2.5 times
more likely to report having a depressed mood at 18 weeks of
pregnancy (OR=2.47, 95% CI 2.13 to 2.86, p,1610
220).
Women who continued smoking during pregnancy reported
slightly higher levels of depressed mood at 18 weeks pregnancy
compared to those who stopped (OR=1.21, 95% CI 0.94 to 1.53,
p=0.133).
Genotype and pre-pregnancy smoking status
The T allele at the rs1051730 locus was present at a frequency of
33% in this study (prevalence of TT=11.22%, CT=44.22%,
CC=44.6%), and genotypes showed little evidence of deviation
from Hardy Weinberg equilibrium (p=0.60). We found that in the
6924 women with EPDS score data at 18 weeks of pregnancy,
rs1051730 genotype was associated with an increased risk of
continuing smoking during pregnancy (per allele effect for each T
allele OR=1.31, 95% CI 1.13 to 1.52, p=0.0004), and with an
increased risk of smoking $10 cigarettes a day pre-pregnancy (per
allele effect for each T allele OR=1.21, 95% CI 1.04 to 1.40,
p=0.013). This is in concordance with a previous report by Freathy
and colleagues (10), who investigated smoking characteristics by
genotype in a larger sample of women from the same cohort.
Genotype and depression
Overall there was very little evidence of an association between
genotype and depressed mood (EPDS$13) at 18 weeks of
pregnancy (per allele OR=0.94, 95% CI 0.84 to 1.05, p=0.25).
Among women who smoked prior to pregnancy, however, the T
allele was associated with a reduced risk of reporting a depressed
mood (per allele OR=0.84, 95% CI 0.72 to 0.99, p=0.034).
Moreover, the risk of depressed mood among TT homozygotes
was almost half that of CC homozygotes (OR=0.56, 95% CI 0.37
to 0.84, p=0.005), with little evidence of an association between
genotype and depressed mood among women who were non-
smokers prior to pregnancy (per allele OR=1.03, 95%CI=0.86–
1.20, p=0.70). There was weak evidence of an interaction
between genotype and smoking prior to pregnancy (p=0.07) on
the risk of depressed mood at 18 weeks of pregnancy. These results
are presented in Table 1. Sensitivity analyses using EPDS score
cut-offs of $10, $11, and $12 among smokers showed that a cut-
off of $12 gave results very similar to those using $13, whereas
using a less stringent EPDS cut-off to define the outcome gave
results which were attenuated (results available on request). Using
data at 32 weeks of pregnancy produce broadly similar findings.
These results are presented in Table 2.
Using rs1051730 genotype as an instrumental variable, the
estimated causal effect of continuing smoking on depressed mood,
on the risk difference scale, was 254.7% (95% CI 2114.3% to
4.8%). This is consistent with a decreased risk of reporting a
depressed mood rather than an increased risk, given continued
smoking during pregnancy.
Discussion
In this study, the rs1051730 T allele, which is associated with
increased number of cigarettes smoked per day and reduced ability
to stop smoking during pregnancy, appears to be associated with
lower levels of reporting of depressed mood. This analysis does not
provide evidence in support of the hypothesis that smoking causes
depressed mood. Women with the T allele were more likely be
heavier smokers prior to pregnancy, and to continue smoking in
the first trimester of pregnancy when pressure to stop smoking was
high, but were less likely to report a depressed mood at 18 weeks of
pregnancy. Our results are consistent with the hypothesis that
tobacco withdrawal causes symptoms of depressed mood, since the
C allele was associated with stopping smoking and with an
increased likelihood of reporting a depressed mood during
pregnancy. However, in this study smoking cessation was
associated with an overall reduction in the reporting of low mood
among pregnant women. Taken together, our results support a
self-medication explanation for the observed association between
smoking and depressed mood symptoms.
Several limitations need to be borne in mind when considering
these results. First, we did not conduct psychiatric interviews to
assess depression, but instead used the EPDS [11] to assess
depressed mood. This is a self-reported questionnaire, which has
been shown to be a valid tool for measuring depression during and
immediately following pregnancy (sensitivity 79%, specificity 85%)
in the UK and elsewhere [13]. However, a high score on the
EPDS does not constitute a diagnosis of depression. Second, once
we had excluded all women with missing data (the main reason
being lack of DNA) we were left with a much smaller subset of the
original ALSPAC study. However, our depressed mood scores
corresponded very well with those reported previously in a much
larger sample [14], suggesting that the women included in this
analysis were representative of the women who took part in the
overall study. Third, whilst it is unlikely that this genetic variant
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EPDS.=13 rs1051730 SNP Total OR (95% CI) p-value
CC CT TT CT versus CC
TT versus
CC Per allele effect
All women
Not depressed 1314
83.8%
1271
83.8%
332
84.0%
2917
83.8%
0.99
(0.82–1.20)
P=0.95
0.98
(0.72–1.32)
P=0.88
0.99
(0.87–1.13)
P=0.89
Depressed 255
16.2%
245
16.2%
63
16.0%
563
16.2%
Total 1569 1516 395 3480
Smokers
Not depressed 448
84.4%
435
83.5%
120
88.9%
1003
84.5%
1.07
(0.77–1.48) P=0.70
0.67
(0.38–1.21) P=0.19
0.91
(0.72–1.15)
P=0.43
Depressed 83
15.6%
86
16.5%
15
11.1%
184
15.5%
Total 531 521 135 1187
Nonsmokers
Not depressed 866
83.4%
836
84.0%
212
81.5%
1914
83.5%
0.96
(0.76–1.21) P=0.72
1.14
(0.80–1.62) P=0.47
1.03
(0.88–1.22)
P=0.70
Depressed 172
16.6%
159
16.0%
48 18.5% 379
16.5%
Total 1038 995 260 2293
P-value for interaction between pre-pregnancy smoking and genotype=0.18 for per allele model.
doi:10.1371/journal.pone.0021689.t002
Table 1. Risk of depression at 18 weeks of pregnancy by rs1051730 genotype, stratified by pre-pregnancy smoking status.
EPDS.=13 rs1051730 SNP Total OR (95% CI) p-value
CC CT TT CT versus CC
TT versus
CC Per allele effect
All women
Not depressed 2423 86.3% 2388
86.0%
629
88.8%
5440
86.4%
1.03
(0.88–1.20)
P=0.72
0.79
(0.61–1.02)
P=0.07
0.94
(0.84–1.05)
P=0.25
Depressed 385
13.7%
390
14.0%
79
11.2%
854
13.6%
Total 2808 2778 708 6294
Smokers
Not depressed 721
77.9%
726
78.0%
201
86.2%
1648
78.8%
0.99
(0.80–1.24) p=0.95
0.56
(0.37–0.84) p=0.005
0.84
(0.72–0.99)
P=0.034
Depressed 205
22.1%
205
22.0%
32
13.7%
442
21.2%
Total 926 931 233 2090
Nonsmokers
Not depressed 1702
90.4%
1662
90.0%
428
90.1
3792
90.2
1.05
(0.85–1.31) p=0.64
1.04
(0.74–1.46) p=0.83
1.03
(0.86–1.20)
P=0.70
Depressed 180
9.6%
185
10.0%
47
9.9%
412
9.8%
Total 1882 1847 475 4204
P-value for interaction between pre-pregnancy smoking and genotype=0.07 for per allele model.
doi:10.1371/journal.pone.0021689.t001
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on smoking, our findings do raise a potential issue of pleiotropy.
This could be addressed in the future by using multiple
independent genetic instruments, which influence smoking
cessation independently via different pathways [15]. In our view,
it is more likely that a synergistic relationship between genotype
and smoking on mood exists, rather than an independent effect of
genotype on depressed mood because there is no effect of genotype
on depression among women who were non-smokers. Fourth, we
did not measure other clinical outcomes related to depressed
mood, such as anxiety. We therefore cannot say to what extent the
relationships we observed reflect anxiety rather than a depressive
tendency. However the co-morbidity of anxiety and depressed
symptoms is so high that it may be difficult to find specific
associations. Fifth, smoking status was assessed by self-report and
without biochemical verification. The use of a genetic marker as a
proxy for smoking status during pregnancy reduces the potential
impact of this limitation, as this is unlikely to vary strongly as a
function of reporting bias. Nevertheless, objective assessment of
smoking status and cigarette consumption would be preferable in
future studies.
A recent study showed that the minor allele of the missense
polymorphism, D398N, in CHRNA5 (rs16969968), which is highly
correlated with the T allele of rs1051730 (r
2=0.79), conferred a
reduced response to a nicotinic agonist in vitro [16]. The a5
nicotinic acetylcholine receptor subunit encoded by this gene
participates in multiple nicotinic receptor subtypes, including the
a4b2a5 subtype that contributes to nicotine-stimulated dopamine
release in the striatum. This region is involved in the reward
pathway and is crucial to the development of substance
dependence [17,18], and may affect mood as well as smoking
behaviour, given that high affinity nicotinic receptors in the brain
can be desensitized by chronic nicotine use, leading to blunted
cholinergic activity and a decrease in depressive symptoms. This
has resulted in nicotinic antagonists recently being tested as
treatments for depression in human subjects, particularly as
adjunctive therapy together with classical antidepressants. There-
fore, smokers may increase nicotine intake to avoid the aversive
effects of withdrawal arising from lower plasma nicotine levels.
Nicotine administration in this context can reduce symptoms of
anxiety and depression, but nicotine also stimulates inhibitory 5-
HT autoreceptors, which can itself be anxiogenic and/or
depressogenic. Individuals with reduced nicotine-cholinergic
receptor activity due to genetic variation may therefore require
greater amounts of nicotine to achieve the same activation of the
dopaminergic pathway.
Our data are not consistent with a causal effect of smoking on
depressed mood, but while we cannot directly conclude from our
data that depressed mood leads to smoking, this is one possible
explanation for the results we observe. Women homozygous for
the rs1051730 T allele, who were least likely to stop smoking
during pregnancy, showed the lowest levels of depressed mood.
This led to an instrumental variable estimate which suggests that
continued smoking during pregnancy reduces the risk of depressed
mood. We propose that there may be two factors determining
whether women continue to smoke during pregnancy. One is
tobacco dependence, which is at least partly influenced by
rs1051730 genotype, and the other is depressed mood. These
mechanisms appear to be largely independent of each other. This
may serve to guide both the treatment of individuals who wish to
stop smoking, and the extent to which tobacco use may be
regarded as a coping strategy. For example, public health
programmes aimed at helping women to stop smoking during
pregnancy should adopt a two-pronged approach to address
women’s general wellbeing, including their mental health.
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